This content is machine translated IBD and SARS-CoV-2 Vulnerable at the mercy of others While COVID-19 mRNA vaccines induce a robust systemic immune response in patients with inflammatory bowel disease (IBD), little is known about their efficacy in the mucosal immune system. Researchers have...…
